EUCTR2007-003856-12-IT
Active, not recruiting
Not Applicable
PREvention of atrial fibrillation in patientS undergoing thorAcic surGEry for lung cance - PRESAGE
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- lung cancer patients undergoing thoracic surgery
- Sponsor
- ISTITUTO EUROPEO DI ONCOLOGIA
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or female patients older than 18 years. Thoracic surgery for lung cancer High peri\-operative values of NT\-proBNP. Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Intollerance to metoprolol and/or losartan History of heart failure Ejection fraction \<50% Permanent FA Treatment with antiarythmics, beta blockers, angiotensin II blockers, ACE inhibitors Sistolic blood pressure \< 95 mmHg
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Prevention of complications during atrial fibrillation ablation with the second-generation cryoballooatrial fibrillationcardiac arrhythmia10007521NL-OMON41330eids Universitair Medisch Centrum75
Not yet recruiting
Phase 3
AtRial fibrillation ablation to prevent disease progression of AF-induced atrial Cardiomyopathy in womEn and meAtrial fibrillation10007521NL-OMON56762niversitair Medisch Centrum Groningen604
Active, not recruiting
Phase 1
dPOST-OPERATIVE ATRIAL FIBRILLATIONMedDRA version: 20.0Level: LLTClassification code 10016566Term: Fibrillation atrialSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2016-002956-25-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE152
Active, not recruiting
Phase 1
Prevention of post-operative Atrial Fibrillation by BOTulinum toxin injections into epicardial fat pads around pulmonary veins in patients undergoing cardiac surgeryEUCTR2018-002541-11-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)220
Completed
Not Applicable
Prevention of Postoperative Atrial Fibrillation after Heart Valve Surgery by L-Carnitine: Study Protocol for An Observational Intervention StudyHeart valve diseasesJPRN-UMIN000025737Hokkaido University Hospital; Department of Cardiovascular and Thoracic Surgery16